nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—CA14—Zoledronate—Paget's disease of bone	0.278	0.438	CbGbCtD
Nilotinib—CA12—Zoledronate—Paget's disease of bone	0.197	0.311	CbGbCtD
Nilotinib—CA2—Zoledronate—Paget's disease of bone	0.159	0.251	CbGbCtD
Nilotinib—BLK—B Cell Receptor Signaling Pathway—INPP5D—Paget's disease of bone	0.000611	0.00456	CbGpPWpGaD
Nilotinib—ABL1—Validated transcriptional targets of TAp63 isoforms—PML—Paget's disease of bone	0.000604	0.00451	CbGpPWpGaD
Nilotinib—LCK—Downstream TCR signaling—INPP5D—Paget's disease of bone	0.000598	0.00446	CbGpPWpGaD
Nilotinib—MAPK11—p73 transcription factor network—PML—Paget's disease of bone	0.000595	0.00444	CbGpPWpGaD
Nilotinib—MAP4K1—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.000583	0.00435	CbGpPWpGaD
Nilotinib—MAPK11—Glucocorticoid receptor regulatory network—BGLAP—Paget's disease of bone	0.000581	0.00433	CbGpPWpGaD
Nilotinib—MAPK14—FGF signaling pathway—BGLAP—Paget's disease of bone	0.000579	0.00432	CbGpPWpGaD
Nilotinib—LCK—Class I PI3K signaling events—INPP5D—Paget's disease of bone	0.000555	0.00414	CbGpPWpGaD
Nilotinib—MAPK14—IL-4 Signaling Pathway—INPP5D—Paget's disease of bone	0.000555	0.00414	CbGpPWpGaD
Nilotinib—HCK—Signaling by Interleukins—SQSTM1—Paget's disease of bone	0.000555	0.00414	CbGpPWpGaD
Nilotinib—LYN—Kit receptor signaling pathway—INPP5D—Paget's disease of bone	0.000545	0.00407	CbGpPWpGaD
Nilotinib—LCK—Interleukin-2 signaling—INPP5D—Paget's disease of bone	0.000536	0.004	CbGpPWpGaD
Nilotinib—MAPK14—AGE/RAGE pathway—ALPL—Paget's disease of bone	0.000532	0.00397	CbGpPWpGaD
Nilotinib—LYN—Fc-epsilon receptor I signaling in mast cells—INPP5D—Paget's disease of bone	0.000531	0.00396	CbGpPWpGaD
Nilotinib—ABL1—Apoptosis-related network due to altered Notch3 in ovarian cancer—SQSTM1—Paget's disease of bone	0.00053	0.00396	CbGpPWpGaD
Nilotinib—EPHA2—NRF2 pathway—SQSTM1—Paget's disease of bone	0.000519	0.00387	CbGpPWpGaD
Nilotinib—ABL1—Regulation of retinoblastoma protein—BGLAP—Paget's disease of bone	0.000518	0.00386	CbGpPWpGaD
Nilotinib—LYN—RANKL/RANK Signaling Pathway—SQSTM1—Paget's disease of bone	0.000517	0.00386	CbGpPWpGaD
Nilotinib—MAPK14—Kit receptor signaling pathway—INPP5D—Paget's disease of bone	0.000517	0.00386	CbGpPWpGaD
Nilotinib—ABL1—DNA Damage Response—PML—Paget's disease of bone	0.000502	0.00375	CbGpPWpGaD
Nilotinib—MAPK8—BDNF signaling pathway—ALPL—Paget's disease of bone	0.000502	0.00374	CbGpPWpGaD
Nilotinib—MAPK14—IL4-mediated signaling events—INPP5D—Paget's disease of bone	0.000497	0.00371	CbGpPWpGaD
Nilotinib—MAPK8—TGF-beta Signaling Pathway—PML—Paget's disease of bone	0.000495	0.00369	CbGpPWpGaD
Nilotinib—MAPK14—Regulation of retinoblastoma protein—BGLAP—Paget's disease of bone	0.000493	0.00368	CbGpPWpGaD
Nilotinib—LYN—BCR signaling pathway—INPP5D—Paget's disease of bone	0.000493	0.00368	CbGpPWpGaD
Nilotinib—MAPK14—RANKL/RANK Signaling Pathway—SQSTM1—Paget's disease of bone	0.00049	0.00366	CbGpPWpGaD
Nilotinib—MAPK14—IL-1 signaling pathway—SQSTM1—Paget's disease of bone	0.00049	0.00366	CbGpPWpGaD
Nilotinib—ABL1—miRNA Regulation of DNA Damage Response—PML—Paget's disease of bone	0.000485	0.00362	CbGpPWpGaD
Nilotinib—BRAF—B Cell Receptor Signaling Pathway—INPP5D—Paget's disease of bone	0.000482	0.0036	CbGpPWpGaD
Nilotinib—MAP2K5—BDNF signaling pathway—ALPL—Paget's disease of bone	0.000477	0.00356	CbGpPWpGaD
Nilotinib—ABL1—Neurotrophic factor-mediated Trk receptor signaling—SQSTM1—Paget's disease of bone	0.000474	0.00354	CbGpPWpGaD
Nilotinib—MAPK14—BCR signaling pathway—INPP5D—Paget's disease of bone	0.000467	0.00349	CbGpPWpGaD
Nilotinib—LCK—TCR signaling—INPP5D—Paget's disease of bone	0.000447	0.00334	CbGpPWpGaD
Nilotinib—ABL1—p73 transcription factor network—PML—Paget's disease of bone	0.000446	0.00332	CbGpPWpGaD
Nilotinib—MAPK14—p73 transcription factor network—PML—Paget's disease of bone	0.000424	0.00317	CbGpPWpGaD
Nilotinib—MAPK8—Cellular responses to stress—VCP—Paget's disease of bone	0.000421	0.00314	CbGpPWpGaD
Nilotinib—HCK—HIV Infection—NUP205—Paget's disease of bone	0.000417	0.00311	CbGpPWpGaD
Nilotinib—MAPK14—Glucocorticoid receptor regulatory network—BGLAP—Paget's disease of bone	0.000414	0.00309	CbGpPWpGaD
Nilotinib—LYN—CXCR4-mediated signaling events—INPP5D—Paget's disease of bone	0.000411	0.00307	CbGpPWpGaD
Nilotinib—MAPK8—Regulation of toll-like receptor signaling pathway—SQSTM1—Paget's disease of bone	0.000411	0.00306	CbGpPWpGaD
Nilotinib—LCK—TCR signaling in naïve CD4+ T cells—INPP5D—Paget's disease of bone	0.000409	0.00305	CbGpPWpGaD
Nilotinib—BRAF—Senescence and Autophagy in Cancer—SQSTM1—Paget's disease of bone	0.000406	0.00303	CbGpPWpGaD
Nilotinib—MAPK8—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.000405	0.00302	CbGpPWpGaD
Nilotinib—Rhinitis—Risedronate—Paget's disease of bone	0.000401	0.00173	CcSEcCtD
Nilotinib—Pollakiuria—Zoledronate—Paget's disease of bone	0.000401	0.00173	CcSEcCtD
Nilotinib—Haemorrhage—Risedronate—Paget's disease of bone	0.0004	0.00172	CcSEcCtD
Nilotinib—MAPK8—BDNF signaling pathway—SQSTM1—Paget's disease of bone	0.000399	0.00298	CbGpPWpGaD
Nilotinib—Pharyngitis—Risedronate—Paget's disease of bone	0.000397	0.00171	CcSEcCtD
Nilotinib—CA9—Cellular responses to stress—VCP—Paget's disease of bone	0.000397	0.00296	CbGpPWpGaD
Nilotinib—Urinary tract disorder—Risedronate—Paget's disease of bone	0.000395	0.0017	CcSEcCtD
Nilotinib—Weight increased—Zoledronate—Paget's disease of bone	0.000395	0.0017	CcSEcCtD
Nilotinib—Oedema peripheral—Risedronate—Paget's disease of bone	0.000394	0.0017	CcSEcCtD
Nilotinib—Connective tissue disorder—Risedronate—Paget's disease of bone	0.000393	0.00169	CcSEcCtD
Nilotinib—Weight decreased—Zoledronate—Paget's disease of bone	0.000392	0.00169	CcSEcCtD
Nilotinib—Urethral disorder—Risedronate—Paget's disease of bone	0.000392	0.00169	CcSEcCtD
Nilotinib—Malaise—Alendronate—Paget's disease of bone	0.000391	0.00169	CcSEcCtD
Nilotinib—Vertigo—Alendronate—Paget's disease of bone	0.00039	0.00168	CcSEcCtD
Nilotinib—Infestation—Zoledronate—Paget's disease of bone	0.000387	0.00167	CcSEcCtD
Nilotinib—Infestation NOS—Zoledronate—Paget's disease of bone	0.000387	0.00167	CcSEcCtD
Nilotinib—MAP2K5—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.000385	0.00288	CbGpPWpGaD
Nilotinib—Haemoglobin—Pamidronate—Paget's disease of bone	0.000382	0.00165	CcSEcCtD
Nilotinib—Rhinitis—Pamidronate—Paget's disease of bone	0.000381	0.00164	CcSEcCtD
Nilotinib—Renal failure—Zoledronate—Paget's disease of bone	0.00038	0.00164	CcSEcCtD
Nilotinib—Haemorrhage—Pamidronate—Paget's disease of bone	0.00038	0.00164	CcSEcCtD
Nilotinib—MAP2K5—BDNF signaling pathway—SQSTM1—Paget's disease of bone	0.00038	0.00283	CbGpPWpGaD
Nilotinib—Musculoskeletal discomfort—Etidronic acid—Paget's disease of bone	0.000379	0.00163	CcSEcCtD
Nilotinib—Stomatitis—Zoledronate—Paget's disease of bone	0.000377	0.00163	CcSEcCtD
Nilotinib—Urinary tract infection—Zoledronate—Paget's disease of bone	0.000376	0.00162	CcSEcCtD
Nilotinib—Conjunctivitis—Zoledronate—Paget's disease of bone	0.000376	0.00162	CcSEcCtD
Nilotinib—Urinary tract disorder—Pamidronate—Paget's disease of bone	0.000375	0.00162	CcSEcCtD
Nilotinib—Eye disorder—Risedronate—Paget's disease of bone	0.000374	0.00161	CcSEcCtD
Nilotinib—Connective tissue disorder—Pamidronate—Paget's disease of bone	0.000373	0.00161	CcSEcCtD
Nilotinib—Paraesthesia—Etidronic acid—Paget's disease of bone	0.000373	0.00161	CcSEcCtD
Nilotinib—Tinnitus—Risedronate—Paget's disease of bone	0.000373	0.00161	CcSEcCtD
Nilotinib—Urethral disorder—Pamidronate—Paget's disease of bone	0.000373	0.00161	CcSEcCtD
Nilotinib—Cardiac disorder—Risedronate—Paget's disease of bone	0.000371	0.0016	CcSEcCtD
Nilotinib—Chest pain—Alendronate—Paget's disease of bone	0.000369	0.00159	CcSEcCtD
Nilotinib—Myalgia—Alendronate—Paget's disease of bone	0.000369	0.00159	CcSEcCtD
Nilotinib—Haematuria—Zoledronate—Paget's disease of bone	0.000369	0.00159	CcSEcCtD
Nilotinib—MAPK8—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.000368	0.00275	CbGpPWpGaD
Nilotinib—LYN—B Cell Receptor Signaling Pathway—INPP5D—Paget's disease of bone	0.000366	0.00273	CbGpPWpGaD
Nilotinib—Dyspepsia—Etidronic acid—Paget's disease of bone	0.000366	0.00158	CcSEcCtD
Nilotinib—Discomfort—Alendronate—Paget's disease of bone	0.000365	0.00157	CcSEcCtD
Nilotinib—Angiopathy—Risedronate—Paget's disease of bone	0.000363	0.00156	CcSEcCtD
Nilotinib—Immune system disorder—Risedronate—Paget's disease of bone	0.000361	0.00156	CcSEcCtD
Nilotinib—LYN—Cell surface interactions at the vascular wall—INPP5D—Paget's disease of bone	0.000361	0.00269	CbGpPWpGaD
Nilotinib—Mediastinal disorder—Risedronate—Paget's disease of bone	0.00036	0.00155	CcSEcCtD
Nilotinib—Arrhythmia—Risedronate—Paget's disease of bone	0.000357	0.00154	CcSEcCtD
Nilotinib—Constipation—Etidronic acid—Paget's disease of bone	0.000355	0.00153	CcSEcCtD
Nilotinib—Eye disorder—Pamidronate—Paget's disease of bone	0.000355	0.00153	CcSEcCtD
Nilotinib—MAPK8—Circadian rythm related genes—PML—Paget's disease of bone	0.000353	0.00264	CbGpPWpGaD
Nilotinib—Bradycardia—Zoledronate—Paget's disease of bone	0.000353	0.00152	CcSEcCtD
Nilotinib—Cardiac disorder—Pamidronate—Paget's disease of bone	0.000353	0.00152	CcSEcCtD
Nilotinib—Flushing—Pamidronate—Paget's disease of bone	0.000353	0.00152	CcSEcCtD
Nilotinib—Infection—Alendronate—Paget's disease of bone	0.000352	0.00152	CcSEcCtD
Nilotinib—BRAF—Integrated Breast Cancer Pathway—PML—Paget's disease of bone	0.000351	0.00262	CbGpPWpGaD
Nilotinib—Mental disorder—Risedronate—Paget's disease of bone	0.00035	0.00151	CcSEcCtD
Nilotinib—Malnutrition—Risedronate—Paget's disease of bone	0.000348	0.0015	CcSEcCtD
Nilotinib—MAPK14—B Cell Receptor Signaling Pathway—INPP5D—Paget's disease of bone	0.000347	0.00259	CbGpPWpGaD
Nilotinib—Hypoaesthesia—Zoledronate—Paget's disease of bone	0.000345	0.00149	CcSEcCtD
Nilotinib—Angiopathy—Pamidronate—Paget's disease of bone	0.000345	0.00149	CcSEcCtD
Nilotinib—Immune system disorder—Pamidronate—Paget's disease of bone	0.000343	0.00148	CcSEcCtD
Nilotinib—Flatulence—Risedronate—Paget's disease of bone	0.000343	0.00148	CcSEcCtD
Nilotinib—Urinary tract disorder—Zoledronate—Paget's disease of bone	0.000343	0.00148	CcSEcCtD
Nilotinib—Mediastinal disorder—Pamidronate—Paget's disease of bone	0.000343	0.00148	CcSEcCtD
Nilotinib—Feeling abnormal—Etidronic acid—Paget's disease of bone	0.000342	0.00148	CcSEcCtD
Nilotinib—Oedema peripheral—Zoledronate—Paget's disease of bone	0.000342	0.00148	CcSEcCtD
Nilotinib—Connective tissue disorder—Zoledronate—Paget's disease of bone	0.000341	0.00147	CcSEcCtD
Nilotinib—Chills—Pamidronate—Paget's disease of bone	0.000341	0.00147	CcSEcCtD
Nilotinib—Urethral disorder—Zoledronate—Paget's disease of bone	0.00034	0.00147	CcSEcCtD
Nilotinib—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.00034	0.00147	CcSEcCtD
Nilotinib—HCK—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.000339	0.00253	CbGpPWpGaD
Nilotinib—LCK—CXCR4-mediated signaling events—INPP5D—Paget's disease of bone	0.000337	0.00251	CbGpPWpGaD
Nilotinib—Back pain—Risedronate—Paget's disease of bone	0.000337	0.00145	CcSEcCtD
Nilotinib—LYN—Signaling by Interleukins—INPP5D—Paget's disease of bone	0.000336	0.00251	CbGpPWpGaD
Nilotinib—Alopecia—Pamidronate—Paget's disease of bone	0.000336	0.00145	CcSEcCtD
Nilotinib—MAPK11—Cellular responses to stress—VCP—Paget's disease of bone	0.000335	0.0025	CbGpPWpGaD
Nilotinib—Muscle spasms—Risedronate—Paget's disease of bone	0.000335	0.00144	CcSEcCtD
Nilotinib—Malnutrition—Pamidronate—Paget's disease of bone	0.000331	0.00143	CcSEcCtD
Nilotinib—Erythema—Pamidronate—Paget's disease of bone	0.000331	0.00143	CcSEcCtD
Nilotinib—Urticaria—Etidronic acid—Paget's disease of bone	0.00033	0.00142	CcSEcCtD
Nilotinib—Abdominal pain—Etidronic acid—Paget's disease of bone	0.000328	0.00142	CcSEcCtD
Nilotinib—MAPK11—Regulation of toll-like receptor signaling pathway—SQSTM1—Paget's disease of bone	0.000327	0.00244	CbGpPWpGaD
Nilotinib—Eye disorder—Zoledronate—Paget's disease of bone	0.000324	0.0014	CcSEcCtD
Nilotinib—Dysgeusia—Pamidronate—Paget's disease of bone	0.000324	0.0014	CcSEcCtD
Nilotinib—Musculoskeletal discomfort—Alendronate—Paget's disease of bone	0.000323	0.00139	CcSEcCtD
Nilotinib—Cardiac disorder—Zoledronate—Paget's disease of bone	0.000322	0.00139	CcSEcCtD
Nilotinib—Flushing—Zoledronate—Paget's disease of bone	0.000322	0.00139	CcSEcCtD
Nilotinib—Anaemia—Risedronate—Paget's disease of bone	0.000322	0.00139	CcSEcCtD
Nilotinib—Back pain—Pamidronate—Paget's disease of bone	0.00032	0.00138	CcSEcCtD
Nilotinib—BRAF—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.00032	0.00239	CbGpPWpGaD
Nilotinib—Muscle spasms—Pamidronate—Paget's disease of bone	0.000318	0.00137	CcSEcCtD
Nilotinib—Angiopathy—Zoledronate—Paget's disease of bone	0.000315	0.00136	CcSEcCtD
Nilotinib—Immune system disorder—Zoledronate—Paget's disease of bone	0.000314	0.00135	CcSEcCtD
Nilotinib—Mediastinal disorder—Zoledronate—Paget's disease of bone	0.000313	0.00135	CcSEcCtD
Nilotinib—Vertigo—Risedronate—Paget's disease of bone	0.000313	0.00135	CcSEcCtD
Nilotinib—Syncope—Risedronate—Paget's disease of bone	0.000312	0.00135	CcSEcCtD
Nilotinib—Dyspepsia—Alendronate—Paget's disease of bone	0.000312	0.00134	CcSEcCtD
Nilotinib—Chills—Zoledronate—Paget's disease of bone	0.000312	0.00134	CcSEcCtD
Nilotinib—Arrhythmia—Zoledronate—Paget's disease of bone	0.00031	0.00134	CcSEcCtD
Nilotinib—Ill-defined disorder—Pamidronate—Paget's disease of bone	0.000307	0.00132	CcSEcCtD
Nilotinib—Alopecia—Zoledronate—Paget's disease of bone	0.000307	0.00132	CcSEcCtD
Nilotinib—Hypersensitivity—Etidronic acid—Paget's disease of bone	0.000306	0.00132	CcSEcCtD
Nilotinib—Loss of consciousness—Risedronate—Paget's disease of bone	0.000306	0.00132	CcSEcCtD
Nilotinib—Anaemia—Pamidronate—Paget's disease of bone	0.000306	0.00132	CcSEcCtD
Nilotinib—Mental disorder—Zoledronate—Paget's disease of bone	0.000304	0.00131	CcSEcCtD
Nilotinib—Cough—Risedronate—Paget's disease of bone	0.000304	0.00131	CcSEcCtD
Nilotinib—Constipation—Alendronate—Paget's disease of bone	0.000303	0.00131	CcSEcCtD
Nilotinib—Pain—Alendronate—Paget's disease of bone	0.000303	0.00131	CcSEcCtD
Nilotinib—Erythema—Zoledronate—Paget's disease of bone	0.000302	0.0013	CcSEcCtD
Nilotinib—Malnutrition—Zoledronate—Paget's disease of bone	0.000302	0.0013	CcSEcCtD
Nilotinib—LYN—Signaling by Interleukins—SQSTM1—Paget's disease of bone	0.000301	0.00225	CbGpPWpGaD
Nilotinib—Hypertension—Risedronate—Paget's disease of bone	0.0003	0.0013	CcSEcCtD
Nilotinib—LCK—B Cell Receptor Signaling Pathway—INPP5D—Paget's disease of bone	0.0003	0.00224	CbGpPWpGaD
Nilotinib—HCK—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.000299	0.00223	CbGpPWpGaD
Nilotinib—Malaise—Pamidronate—Paget's disease of bone	0.000298	0.00129	CcSEcCtD
Nilotinib—Syncope—Pamidronate—Paget's disease of bone	0.000297	0.00128	CcSEcCtD
Nilotinib—Chest pain—Risedronate—Paget's disease of bone	0.000296	0.00128	CcSEcCtD
Nilotinib—Arthralgia—Risedronate—Paget's disease of bone	0.000296	0.00128	CcSEcCtD
Nilotinib—Myalgia—Risedronate—Paget's disease of bone	0.000296	0.00128	CcSEcCtD
Nilotinib—Leukopenia—Pamidronate—Paget's disease of bone	0.000296	0.00128	CcSEcCtD
Nilotinib—Dysgeusia—Zoledronate—Paget's disease of bone	0.000296	0.00128	CcSEcCtD
Nilotinib—LCK—Cell surface interactions at the vascular wall—INPP5D—Paget's disease of bone	0.000295	0.00221	CbGpPWpGaD
Nilotinib—Anxiety—Risedronate—Paget's disease of bone	0.000295	0.00127	CcSEcCtD
Nilotinib—Unspecified disorder of skin and subcutaneous tissue—Risedronate—Paget's disease of bone	0.000294	0.00127	CcSEcCtD
Nilotinib—Pruritus—Etidronic acid—Paget's disease of bone	0.000294	0.00127	CcSEcCtD
Nilotinib—Back pain—Zoledronate—Paget's disease of bone	0.000292	0.00126	CcSEcCtD
Nilotinib—MAPK14—Senescence and Autophagy in Cancer—SQSTM1—Paget's disease of bone	0.000292	0.00218	CbGpPWpGaD
Nilotinib—Feeling abnormal—Alendronate—Paget's disease of bone	0.000292	0.00126	CcSEcCtD
Nilotinib—Loss of consciousness—Pamidronate—Paget's disease of bone	0.000291	0.00125	CcSEcCtD
Nilotinib—Muscle spasms—Zoledronate—Paget's disease of bone	0.000291	0.00125	CcSEcCtD
Nilotinib—Dry mouth—Risedronate—Paget's disease of bone	0.00029	0.00125	CcSEcCtD
Nilotinib—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.000289	0.00125	CcSEcCtD
Nilotinib—HCK—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.000289	0.00215	CbGpPWpGaD
Nilotinib—Cough—Pamidronate—Paget's disease of bone	0.000289	0.00125	CcSEcCtD
Nilotinib—LCK—Host Interactions of HIV factors—NUP205—Paget's disease of bone	0.000286	0.00213	CbGpPWpGaD
Nilotinib—Hypertension—Pamidronate—Paget's disease of bone	0.000286	0.00123	CcSEcCtD
Nilotinib—MAPK14—BDNF signaling pathway—ALPL—Paget's disease of bone	0.000285	0.00213	CbGpPWpGaD
Nilotinib—Vision blurred—Zoledronate—Paget's disease of bone	0.000285	0.00123	CcSEcCtD
Nilotinib—Diarrhoea—Etidronic acid—Paget's disease of bone	0.000284	0.00123	CcSEcCtD
Nilotinib—Tremor—Zoledronate—Paget's disease of bone	0.000283	0.00122	CcSEcCtD
Nilotinib—Infection—Risedronate—Paget's disease of bone	0.000282	0.00122	CcSEcCtD
Nilotinib—Myalgia—Pamidronate—Paget's disease of bone	0.000282	0.00121	CcSEcCtD
Nilotinib—Arthralgia—Pamidronate—Paget's disease of bone	0.000282	0.00121	CcSEcCtD
Nilotinib—MAPK14—TGF-beta Signaling Pathway—PML—Paget's disease of bone	0.000281	0.0021	CbGpPWpGaD
Nilotinib—Urticaria—Alendronate—Paget's disease of bone	0.000281	0.00121	CcSEcCtD
Nilotinib—Anxiety—Pamidronate—Paget's disease of bone	0.000281	0.00121	CcSEcCtD
Nilotinib—Ill-defined disorder—Zoledronate—Paget's disease of bone	0.00028	0.00121	CcSEcCtD
Nilotinib—Abdominal pain—Alendronate—Paget's disease of bone	0.00028	0.00121	CcSEcCtD
Nilotinib—Body temperature increased—Alendronate—Paget's disease of bone	0.00028	0.00121	CcSEcCtD
Nilotinib—Shock—Risedronate—Paget's disease of bone	0.000279	0.00121	CcSEcCtD
Nilotinib—Anaemia—Zoledronate—Paget's disease of bone	0.000279	0.0012	CcSEcCtD
Nilotinib—Nervous system disorder—Risedronate—Paget's disease of bone	0.000279	0.0012	CcSEcCtD
Nilotinib—Discomfort—Pamidronate—Paget's disease of bone	0.000278	0.0012	CcSEcCtD
Nilotinib—Skin disorder—Risedronate—Paget's disease of bone	0.000276	0.00119	CcSEcCtD
Nilotinib—LCK—Signaling by Interleukins—INPP5D—Paget's disease of bone	0.000276	0.00206	CbGpPWpGaD
Nilotinib—Malaise—Zoledronate—Paget's disease of bone	0.000273	0.00118	CcSEcCtD
Nilotinib—Confusional state—Pamidronate—Paget's disease of bone	0.000272	0.00117	CcSEcCtD
Nilotinib—Vertigo—Zoledronate—Paget's disease of bone	0.000272	0.00117	CcSEcCtD
Nilotinib—Syncope—Zoledronate—Paget's disease of bone	0.000271	0.00117	CcSEcCtD
Nilotinib—Leukopenia—Zoledronate—Paget's disease of bone	0.000271	0.00117	CcSEcCtD
Nilotinib—Oedema—Pamidronate—Paget's disease of bone	0.00027	0.00116	CcSEcCtD
Nilotinib—Infection—Pamidronate—Paget's disease of bone	0.000268	0.00116	CcSEcCtD
Nilotinib—Palpitations—Zoledronate—Paget's disease of bone	0.000267	0.00115	CcSEcCtD
Nilotinib—Shock—Pamidronate—Paget's disease of bone	0.000266	0.00115	CcSEcCtD
Nilotinib—Loss of consciousness—Zoledronate—Paget's disease of bone	0.000266	0.00115	CcSEcCtD
Nilotinib—ABL1—Integrated Breast Cancer Pathway—PML—Paget's disease of bone	0.000265	0.00198	CbGpPWpGaD
Nilotinib—Nervous system disorder—Pamidronate—Paget's disease of bone	0.000265	0.00114	CcSEcCtD
Nilotinib—Thrombocytopenia—Pamidronate—Paget's disease of bone	0.000264	0.00114	CcSEcCtD
Nilotinib—Vomiting—Etidronic acid—Paget's disease of bone	0.000264	0.00114	CcSEcCtD
Nilotinib—Cough—Zoledronate—Paget's disease of bone	0.000264	0.00114	CcSEcCtD
Nilotinib—Tachycardia—Pamidronate—Paget's disease of bone	0.000264	0.00114	CcSEcCtD
Nilotinib—Rash—Etidronic acid—Paget's disease of bone	0.000262	0.00113	CcSEcCtD
Nilotinib—Dermatitis—Etidronic acid—Paget's disease of bone	0.000262	0.00113	CcSEcCtD
Nilotinib—Hyperhidrosis—Pamidronate—Paget's disease of bone	0.000261	0.00113	CcSEcCtD
Nilotinib—Hypertension—Zoledronate—Paget's disease of bone	0.000261	0.00113	CcSEcCtD
Nilotinib—Hypersensitivity—Alendronate—Paget's disease of bone	0.000261	0.00113	CcSEcCtD
Nilotinib—Headache—Etidronic acid—Paget's disease of bone	0.00026	0.00112	CcSEcCtD
Nilotinib—HCK—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000259	0.00193	CbGpPWpGaD
Nilotinib—Musculoskeletal discomfort—Risedronate—Paget's disease of bone	0.000259	0.00112	CcSEcCtD
Nilotinib—Anorexia—Pamidronate—Paget's disease of bone	0.000257	0.00111	CcSEcCtD
Nilotinib—Arthralgia—Zoledronate—Paget's disease of bone	0.000257	0.00111	CcSEcCtD
Nilotinib—Myalgia—Zoledronate—Paget's disease of bone	0.000257	0.00111	CcSEcCtD
Nilotinib—Chest pain—Zoledronate—Paget's disease of bone	0.000257	0.00111	CcSEcCtD
Nilotinib—Insomnia—Risedronate—Paget's disease of bone	0.000257	0.00111	CcSEcCtD
Nilotinib—Anxiety—Zoledronate—Paget's disease of bone	0.000256	0.00111	CcSEcCtD
Nilotinib—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—Paget's disease of bone	0.000256	0.0011	CcSEcCtD
Nilotinib—Paraesthesia—Risedronate—Paget's disease of bone	0.000255	0.0011	CcSEcCtD
Nilotinib—MAPK11—Metabolism of RNA—NUP205—Paget's disease of bone	0.000255	0.0019	CbGpPWpGaD
Nilotinib—Discomfort—Zoledronate—Paget's disease of bone	0.000254	0.0011	CcSEcCtD
Nilotinib—Asthenia—Alendronate—Paget's disease of bone	0.000254	0.0011	CcSEcCtD
Nilotinib—Dyspnoea—Risedronate—Paget's disease of bone	0.000253	0.00109	CcSEcCtD
Nilotinib—Hypotension—Pamidronate—Paget's disease of bone	0.000252	0.00109	CcSEcCtD
Nilotinib—TEK—Hemostasis—INPP5D—Paget's disease of bone	0.000252	0.00188	CbGpPWpGaD
Nilotinib—Dry mouth—Zoledronate—Paget's disease of bone	0.000252	0.00109	CcSEcCtD
Nilotinib—Pruritus—Alendronate—Paget's disease of bone	0.00025	0.00108	CcSEcCtD
Nilotinib—PDGFRA—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.00025	0.00187	CbGpPWpGaD
Nilotinib—Dyspepsia—Risedronate—Paget's disease of bone	0.00025	0.00108	CcSEcCtD
Nilotinib—Confusional state—Zoledronate—Paget's disease of bone	0.000249	0.00107	CcSEcCtD
Nilotinib—LCK—Signaling by Interleukins—SQSTM1—Paget's disease of bone	0.000247	0.00184	CbGpPWpGaD
Nilotinib—Nausea—Etidronic acid—Paget's disease of bone	0.000247	0.00106	CcSEcCtD
Nilotinib—Oedema—Zoledronate—Paget's disease of bone	0.000247	0.00106	CcSEcCtD
Nilotinib—Musculoskeletal discomfort—Pamidronate—Paget's disease of bone	0.000246	0.00106	CcSEcCtD
Nilotinib—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.000245	0.00106	CcSEcCtD
Nilotinib—Infection—Zoledronate—Paget's disease of bone	0.000245	0.00106	CcSEcCtD
Nilotinib—Fatigue—Risedronate—Paget's disease of bone	0.000245	0.00106	CcSEcCtD
Nilotinib—Insomnia—Pamidronate—Paget's disease of bone	0.000244	0.00105	CcSEcCtD
Nilotinib—Constipation—Risedronate—Paget's disease of bone	0.000243	0.00105	CcSEcCtD
Nilotinib—Pain—Risedronate—Paget's disease of bone	0.000243	0.00105	CcSEcCtD
Nilotinib—Shock—Zoledronate—Paget's disease of bone	0.000243	0.00105	CcSEcCtD
Nilotinib—Paraesthesia—Pamidronate—Paget's disease of bone	0.000242	0.00105	CcSEcCtD
Nilotinib—Diarrhoea—Alendronate—Paget's disease of bone	0.000242	0.00104	CcSEcCtD
Nilotinib—ABL1—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.000242	0.00181	CbGpPWpGaD
Nilotinib—Nervous system disorder—Zoledronate—Paget's disease of bone	0.000242	0.00104	CcSEcCtD
Nilotinib—Thrombocytopenia—Zoledronate—Paget's disease of bone	0.000241	0.00104	CcSEcCtD
Nilotinib—Dyspnoea—Pamidronate—Paget's disease of bone	0.000241	0.00104	CcSEcCtD
Nilotinib—Tachycardia—Zoledronate—Paget's disease of bone	0.000241	0.00104	CcSEcCtD
Nilotinib—Skin disorder—Zoledronate—Paget's disease of bone	0.00024	0.00103	CcSEcCtD
Nilotinib—MAPK14—Cellular responses to stress—VCP—Paget's disease of bone	0.000239	0.00179	CbGpPWpGaD
Nilotinib—Hyperhidrosis—Zoledronate—Paget's disease of bone	0.000238	0.00103	CcSEcCtD
Nilotinib—Dyspepsia—Pamidronate—Paget's disease of bone	0.000238	0.00103	CcSEcCtD
Nilotinib—Anorexia—Zoledronate—Paget's disease of bone	0.000235	0.00101	CcSEcCtD
Nilotinib—Decreased appetite—Pamidronate—Paget's disease of bone	0.000235	0.00101	CcSEcCtD
Nilotinib—Dizziness—Alendronate—Paget's disease of bone	0.000234	0.00101	CcSEcCtD
Nilotinib—MAPK14—Regulation of toll-like receptor signaling pathway—SQSTM1—Paget's disease of bone	0.000234	0.00174	CbGpPWpGaD
Nilotinib—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.000233	0.00101	CcSEcCtD
Nilotinib—Fatigue—Pamidronate—Paget's disease of bone	0.000233	0.001	CcSEcCtD
Nilotinib—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.000232	0.001	CcSEcCtD
Nilotinib—Pain—Pamidronate—Paget's disease of bone	0.000231	0.000996	CcSEcCtD
Nilotinib—Constipation—Pamidronate—Paget's disease of bone	0.000231	0.000996	CcSEcCtD
Nilotinib—MAPK8—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000231	0.00172	CbGpPWpGaD
Nilotinib—Hypotension—Zoledronate—Paget's disease of bone	0.00023	0.000994	CcSEcCtD
Nilotinib—MAPK14—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.00023	0.00172	CbGpPWpGaD
Nilotinib—MAPK14—BDNF signaling pathway—SQSTM1—Paget's disease of bone	0.000227	0.00169	CbGpPWpGaD
Nilotinib—Urticaria—Risedronate—Paget's disease of bone	0.000226	0.000973	CcSEcCtD
Nilotinib—Vomiting—Alendronate—Paget's disease of bone	0.000225	0.000971	CcSEcCtD
Nilotinib—Musculoskeletal discomfort—Zoledronate—Paget's disease of bone	0.000225	0.000969	CcSEcCtD
Nilotinib—Abdominal pain—Risedronate—Paget's disease of bone	0.000225	0.000969	CcSEcCtD
Nilotinib—Body temperature increased—Risedronate—Paget's disease of bone	0.000225	0.000969	CcSEcCtD
Nilotinib—Rash—Alendronate—Paget's disease of bone	0.000223	0.000963	CcSEcCtD
Nilotinib—Insomnia—Zoledronate—Paget's disease of bone	0.000223	0.000962	CcSEcCtD
Nilotinib—Dermatitis—Alendronate—Paget's disease of bone	0.000223	0.000962	CcSEcCtD
Nilotinib—Feeling abnormal—Pamidronate—Paget's disease of bone	0.000223	0.00096	CcSEcCtD
Nilotinib—Headache—Alendronate—Paget's disease of bone	0.000222	0.000957	CcSEcCtD
Nilotinib—UGT1A1—NRF2 pathway—SQSTM1—Paget's disease of bone	0.000222	0.00165	CbGpPWpGaD
Nilotinib—Paraesthesia—Zoledronate—Paget's disease of bone	0.000221	0.000955	CcSEcCtD
Nilotinib—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.000221	0.000952	CcSEcCtD
Nilotinib—Dyspnoea—Zoledronate—Paget's disease of bone	0.00022	0.000948	CcSEcCtD
Nilotinib—ABL1—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.00022	0.00164	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000219	0.00164	CbGpPWpGaD
Nilotinib—Dyspepsia—Zoledronate—Paget's disease of bone	0.000217	0.000936	CcSEcCtD
Nilotinib—Decreased appetite—Zoledronate—Paget's disease of bone	0.000214	0.000925	CcSEcCtD
Nilotinib—Abdominal pain—Pamidronate—Paget's disease of bone	0.000213	0.000921	CcSEcCtD
Nilotinib—Body temperature increased—Pamidronate—Paget's disease of bone	0.000213	0.000921	CcSEcCtD
Nilotinib—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.000213	0.000918	CcSEcCtD
Nilotinib—Fatigue—Zoledronate—Paget's disease of bone	0.000213	0.000917	CcSEcCtD
Nilotinib—Pain—Zoledronate—Paget's disease of bone	0.000211	0.00091	CcSEcCtD
Nilotinib—Constipation—Zoledronate—Paget's disease of bone	0.000211	0.00091	CcSEcCtD
Nilotinib—Nausea—Alendronate—Paget's disease of bone	0.00021	0.000907	CcSEcCtD
Nilotinib—MAPK14—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.000209	0.00156	CbGpPWpGaD
Nilotinib—Hypersensitivity—Risedronate—Paget's disease of bone	0.000209	0.000903	CcSEcCtD
Nilotinib—CA3—Metabolism—NUP205—Paget's disease of bone	0.000209	0.00156	CbGpPWpGaD
Nilotinib—Asthenia—Risedronate—Paget's disease of bone	0.000204	0.000879	CcSEcCtD
Nilotinib—Feeling abnormal—Zoledronate—Paget's disease of bone	0.000203	0.000877	CcSEcCtD
Nilotinib—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.000202	0.00087	CcSEcCtD
Nilotinib—Pruritus—Risedronate—Paget's disease of bone	0.000201	0.000867	CcSEcCtD
Nilotinib—Hypersensitivity—Pamidronate—Paget's disease of bone	0.000199	0.000858	CcSEcCtD
Nilotinib—Urticaria—Zoledronate—Paget's disease of bone	0.000196	0.000845	CcSEcCtD
Nilotinib—Body temperature increased—Zoledronate—Paget's disease of bone	0.000195	0.000841	CcSEcCtD
Nilotinib—Abdominal pain—Zoledronate—Paget's disease of bone	0.000195	0.000841	CcSEcCtD
Nilotinib—Diarrhoea—Risedronate—Paget's disease of bone	0.000194	0.000838	CcSEcCtD
Nilotinib—Asthenia—Pamidronate—Paget's disease of bone	0.000194	0.000836	CcSEcCtD
Nilotinib—Pruritus—Pamidronate—Paget's disease of bone	0.000191	0.000824	CcSEcCtD
Nilotinib—Dizziness—Risedronate—Paget's disease of bone	0.000188	0.00081	CcSEcCtD
Nilotinib—LCK—HIV Infection—NUP205—Paget's disease of bone	0.000186	0.00139	CbGpPWpGaD
Nilotinib—Diarrhoea—Pamidronate—Paget's disease of bone	0.000185	0.000797	CcSEcCtD
Nilotinib—LYN—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.000184	0.00137	CbGpPWpGaD
Nilotinib—MAPK11—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000184	0.00137	CbGpPWpGaD
Nilotinib—BRAF—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000182	0.00136	CbGpPWpGaD
Nilotinib—MAPK14—Metabolism of RNA—NUP205—Paget's disease of bone	0.000182	0.00136	CbGpPWpGaD
Nilotinib—Hypersensitivity—Zoledronate—Paget's disease of bone	0.000182	0.000784	CcSEcCtD
Nilotinib—Vomiting—Risedronate—Paget's disease of bone	0.000181	0.000779	CcSEcCtD
Nilotinib—Rash—Risedronate—Paget's disease of bone	0.000179	0.000773	CcSEcCtD
Nilotinib—Dermatitis—Risedronate—Paget's disease of bone	0.000179	0.000772	CcSEcCtD
Nilotinib—Dizziness—Pamidronate—Paget's disease of bone	0.000179	0.00077	CcSEcCtD
Nilotinib—Headache—Risedronate—Paget's disease of bone	0.000178	0.000768	CcSEcCtD
Nilotinib—CA3—Metabolism—INPP5D—Paget's disease of bone	0.000178	0.00133	CbGpPWpGaD
Nilotinib—Asthenia—Zoledronate—Paget's disease of bone	0.000177	0.000763	CcSEcCtD
Nilotinib—Pruritus—Zoledronate—Paget's disease of bone	0.000175	0.000753	CcSEcCtD
Nilotinib—Vomiting—Pamidronate—Paget's disease of bone	0.000172	0.000741	CcSEcCtD
Nilotinib—Rash—Pamidronate—Paget's disease of bone	0.00017	0.000734	CcSEcCtD
Nilotinib—Dermatitis—Pamidronate—Paget's disease of bone	0.00017	0.000734	CcSEcCtD
Nilotinib—Headache—Pamidronate—Paget's disease of bone	0.000169	0.00073	CcSEcCtD
Nilotinib—Diarrhoea—Zoledronate—Paget's disease of bone	0.000169	0.000728	CcSEcCtD
Nilotinib—Nausea—Risedronate—Paget's disease of bone	0.000169	0.000728	CcSEcCtD
Nilotinib—KIT—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000166	0.00124	CbGpPWpGaD
Nilotinib—Dizziness—Zoledronate—Paget's disease of bone	0.000163	0.000704	CcSEcCtD
Nilotinib—LYN—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.000163	0.00121	CbGpPWpGaD
Nilotinib—FGR—Hemostasis—INPP5D—Paget's disease of bone	0.000162	0.00121	CbGpPWpGaD
Nilotinib—Nausea—Pamidronate—Paget's disease of bone	0.00016	0.000692	CcSEcCtD
Nilotinib—LYN—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.000157	0.00117	CbGpPWpGaD
Nilotinib—Vomiting—Zoledronate—Paget's disease of bone	0.000157	0.000676	CcSEcCtD
Nilotinib—PDGFRA—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000157	0.00117	CbGpPWpGaD
Nilotinib—Rash—Zoledronate—Paget's disease of bone	0.000156	0.000671	CcSEcCtD
Nilotinib—Dermatitis—Zoledronate—Paget's disease of bone	0.000155	0.00067	CcSEcCtD
Nilotinib—Headache—Zoledronate—Paget's disease of bone	0.000155	0.000666	CcSEcCtD
Nilotinib—LCK—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.000151	0.00113	CbGpPWpGaD
Nilotinib—Nausea—Zoledronate—Paget's disease of bone	0.000147	0.000632	CcSEcCtD
Nilotinib—PDGFRB—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000141	0.00105	CbGpPWpGaD
Nilotinib—BLK—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000141	0.00105	CbGpPWpGaD
Nilotinib—LYN—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000141	0.00105	CbGpPWpGaD
Nilotinib—CA14—Metabolism—NUP205—Paget's disease of bone	0.000134	0.001	CbGpPWpGaD
Nilotinib—HCK—Disease—VCP—Paget's disease of bone	0.000134	0.000997	CbGpPWpGaD
Nilotinib—LCK—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.000133	0.000995	CbGpPWpGaD
Nilotinib—MAPK14—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000131	0.000978	CbGpPWpGaD
Nilotinib—CA6—Metabolism—NUP205—Paget's disease of bone	0.000131	0.000978	CbGpPWpGaD
Nilotinib—LCK—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.000129	0.00096	CbGpPWpGaD
Nilotinib—CA7—Metabolism—NUP205—Paget's disease of bone	0.000122	0.000913	CbGpPWpGaD
Nilotinib—LCK—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000115	0.00086	CbGpPWpGaD
Nilotinib—CA14—Metabolism—INPP5D—Paget's disease of bone	0.000115	0.000855	CbGpPWpGaD
Nilotinib—LCK—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000113	0.000846	CbGpPWpGaD
Nilotinib—CA12—Metabolism—NUP205—Paget's disease of bone	0.000113	0.000846	CbGpPWpGaD
Nilotinib—CA6—Metabolism—INPP5D—Paget's disease of bone	0.000112	0.000834	CbGpPWpGaD
Nilotinib—HCK—Immune System—NUP205—Paget's disease of bone	0.000111	0.000825	CbGpPWpGaD
Nilotinib—CA7—Metabolism—INPP5D—Paget's disease of bone	0.000104	0.000778	CbGpPWpGaD
Nilotinib—HCK—Disease—NUP205—Paget's disease of bone	0.000102	0.000762	CbGpPWpGaD
Nilotinib—KIT—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000101	0.000755	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—NUP205—Paget's disease of bone	0.0001	0.000748	CbGpPWpGaD
Nilotinib—BLK—Immune System—NUP205—Paget's disease of bone	0.0001	0.000748	CbGpPWpGaD
Nilotinib—FGR—Immune System—NUP205—Paget's disease of bone	9.99e-05	0.000745	CbGpPWpGaD
Nilotinib—LYN—Hemostasis—INPP5D—Paget's disease of bone	9.77e-05	0.000729	CbGpPWpGaD
Nilotinib—HCK—Immune System—PML—Paget's disease of bone	9.77e-05	0.000729	CbGpPWpGaD
Nilotinib—ABL1—Hemostasis—INPP5D—Paget's disease of bone	9.73e-05	0.000726	CbGpPWpGaD
Nilotinib—CA12—Metabolism—INPP5D—Paget's disease of bone	9.66e-05	0.000721	CbGpPWpGaD
Nilotinib—PDGFRA—Adaptive Immune System—INPP5D—Paget's disease of bone	9.58e-05	0.000715	CbGpPWpGaD
Nilotinib—BRAF—Disease—VCP—Paget's disease of bone	9.55e-05	0.000713	CbGpPWpGaD
Nilotinib—ABCB1—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	9.48e-05	0.000708	CbGpPWpGaD
Nilotinib—HCK—Immune System—INPP5D—Paget's disease of bone	9.43e-05	0.000704	CbGpPWpGaD
Nilotinib—MAPK14—Hemostasis—INPP5D—Paget's disease of bone	9.27e-05	0.000691	CbGpPWpGaD
Nilotinib—CA4—Metabolism—NUP205—Paget's disease of bone	9.04e-05	0.000674	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—PML—Paget's disease of bone	8.86e-05	0.000661	CbGpPWpGaD
Nilotinib—BLK—Immune System—PML—Paget's disease of bone	8.86e-05	0.000661	CbGpPWpGaD
Nilotinib—FGR—Immune System—PML—Paget's disease of bone	8.83e-05	0.000659	CbGpPWpGaD
Nilotinib—KIT—Disease—VCP—Paget's disease of bone	8.7e-05	0.000649	CbGpPWpGaD
Nilotinib—CA2—Metabolism—NUP205—Paget's disease of bone	8.66e-05	0.000646	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—INPP5D—Paget's disease of bone	8.63e-05	0.000644	CbGpPWpGaD
Nilotinib—BLK—Immune System—INPP5D—Paget's disease of bone	8.54e-05	0.000638	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—INPP5D—Paget's disease of bone	8.54e-05	0.000638	CbGpPWpGaD
Nilotinib—FGR—Immune System—INPP5D—Paget's disease of bone	8.52e-05	0.000635	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—VCP—Paget's disease of bone	8.48e-05	0.000633	CbGpPWpGaD
Nilotinib—HCK—Immune System—SQSTM1—Paget's disease of bone	8.45e-05	0.000631	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—INPP5D—Paget's disease of bone	8.45e-05	0.000631	CbGpPWpGaD
Nilotinib—CA1—Metabolism—NUP205—Paget's disease of bone	8.31e-05	0.00062	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—VCP—Paget's disease of bone	8.23e-05	0.000614	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—VCP—Paget's disease of bone	8.06e-05	0.000601	CbGpPWpGaD
Nilotinib—LCK—Hemostasis—INPP5D—Paget's disease of bone	8.01e-05	0.000598	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—NUP205—Paget's disease of bone	7.98e-05	0.000596	CbGpPWpGaD
Nilotinib—MAPK11—Gene Expression—NUP205—Paget's disease of bone	7.94e-05	0.000592	CbGpPWpGaD
Nilotinib—ABCG2—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	7.88e-05	0.000588	CbGpPWpGaD
Nilotinib—CA4—Metabolism—INPP5D—Paget's disease of bone	7.71e-05	0.000575	CbGpPWpGaD
Nilotinib—BLK—Immune System—SQSTM1—Paget's disease of bone	7.66e-05	0.000572	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—SQSTM1—Paget's disease of bone	7.66e-05	0.000572	CbGpPWpGaD
Nilotinib—FGR—Immune System—SQSTM1—Paget's disease of bone	7.63e-05	0.00057	CbGpPWpGaD
Nilotinib—HCK—Disease—CALCA—Paget's disease of bone	7.58e-05	0.000566	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—VCP—Paget's disease of bone	7.42e-05	0.000553	CbGpPWpGaD
Nilotinib—CA2—Metabolism—INPP5D—Paget's disease of bone	7.39e-05	0.000551	CbGpPWpGaD
Nilotinib—BRAF—Disease—NUP205—Paget's disease of bone	7.3e-05	0.000545	CbGpPWpGaD
Nilotinib—CA9—Metabolism—NUP205—Paget's disease of bone	7.3e-05	0.000545	CbGpPWpGaD
Nilotinib—KIT—Immune System—NUP205—Paget's disease of bone	7.2e-05	0.000537	CbGpPWpGaD
Nilotinib—CA1—Metabolism—INPP5D—Paget's disease of bone	7.08e-05	0.000529	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—PML—Paget's disease of bone	7.06e-05	0.000527	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—INPP5D—Paget's disease of bone	6.93e-05	0.000517	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—NUP205—Paget's disease of bone	6.81e-05	0.000509	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—INPP5D—Paget's disease of bone	6.81e-05	0.000508	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—VCP—Paget's disease of bone	6.75e-05	0.000504	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—VCP—Paget's disease of bone	6.69e-05	0.000499	CbGpPWpGaD
Nilotinib—KIT—Disease—NUP205—Paget's disease of bone	6.65e-05	0.000496	CbGpPWpGaD
Nilotinib—KIT—Immune System—PML—Paget's disease of bone	6.36e-05	0.000475	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—NUP205—Paget's disease of bone	6.29e-05	0.000469	CbGpPWpGaD
Nilotinib—CA9—Metabolism—INPP5D—Paget's disease of bone	6.23e-05	0.000465	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—NUP205—Paget's disease of bone	6.14e-05	0.000458	CbGpPWpGaD
Nilotinib—KIT—Immune System—INPP5D—Paget's disease of bone	6.14e-05	0.000458	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—SQSTM1—Paget's disease of bone	6.1e-05	0.000455	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—VCP—Paget's disease of bone	6.09e-05	0.000454	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—PML—Paget's disease of bone	6.02e-05	0.000449	CbGpPWpGaD
Nilotinib—LYN—Immune System—NUP205—Paget's disease of bone	6.01e-05	0.000449	CbGpPWpGaD
Nilotinib—ABL1—Immune System—NUP205—Paget's disease of bone	5.98e-05	0.000446	CbGpPWpGaD
Nilotinib—LCK—Disease—VCP—Paget's disease of bone	5.95e-05	0.000444	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—INPP5D—Paget's disease of bone	5.81e-05	0.000434	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—VCP—Paget's disease of bone	5.76e-05	0.00043	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—NUP205—Paget's disease of bone	5.7e-05	0.000425	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—NUP205—Paget's disease of bone	5.67e-05	0.000423	CbGpPWpGaD
Nilotinib—MAPK14—Gene Expression—NUP205—Paget's disease of bone	5.67e-05	0.000423	CbGpPWpGaD
Nilotinib—KIT—Immune System—SQSTM1—Paget's disease of bone	5.5e-05	0.000411	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—PML—Paget's disease of bone	5.43e-05	0.000405	CbGpPWpGaD
Nilotinib—BRAF—Disease—CALCA—Paget's disease of bone	5.42e-05	0.000404	CbGpPWpGaD
Nilotinib—LYN—Immune System—PML—Paget's disease of bone	5.31e-05	0.000396	CbGpPWpGaD
Nilotinib—ABL1—Immune System—PML—Paget's disease of bone	5.29e-05	0.000395	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—INPP5D—Paget's disease of bone	5.24e-05	0.000391	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—SQSTM1—Paget's disease of bone	5.21e-05	0.000389	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—VCP—Paget's disease of bone	5.19e-05	0.000388	CbGpPWpGaD
Nilotinib—LYN—Immune System—INPP5D—Paget's disease of bone	5.13e-05	0.000382	CbGpPWpGaD
Nilotinib—ABL1—Immune System—INPP5D—Paget's disease of bone	5.1e-05	0.000381	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—VCP—Paget's disease of bone	5.08e-05	0.000379	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—PML—Paget's disease of bone	5.04e-05	0.000376	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—SQSTM1—Paget's disease of bone	4.95e-05	0.00037	CbGpPWpGaD
Nilotinib—KIT—Disease—CALCA—Paget's disease of bone	4.93e-05	0.000368	CbGpPWpGaD
Nilotinib—LCK—Immune System—NUP205—Paget's disease of bone	4.93e-05	0.000368	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—INPP5D—Paget's disease of bone	4.86e-05	0.000363	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—VCP—Paget's disease of bone	4.82e-05	0.00036	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—CALCA—Paget's disease of bone	4.81e-05	0.000359	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—SQSTM1—Paget's disease of bone	4.71e-05	0.000351	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—SQSTM1—Paget's disease of bone	4.69e-05	0.00035	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—CALCA—Paget's disease of bone	4.67e-05	0.000349	CbGpPWpGaD
Nilotinib—LYN—Immune System—SQSTM1—Paget's disease of bone	4.59e-05	0.000343	CbGpPWpGaD
Nilotinib—ABL1—Immune System—SQSTM1—Paget's disease of bone	4.57e-05	0.000341	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—CALCA—Paget's disease of bone	4.57e-05	0.000341	CbGpPWpGaD
Nilotinib—LCK—Disease—NUP205—Paget's disease of bone	4.55e-05	0.000339	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	4.39e-05	0.000327	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—SQSTM1—Paget's disease of bone	4.36e-05	0.000325	CbGpPWpGaD
Nilotinib—LCK—Immune System—PML—Paget's disease of bone	4.35e-05	0.000325	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—NUP205—Paget's disease of bone	4.35e-05	0.000325	CbGpPWpGaD
Nilotinib—ABCB1—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	4.26e-05	0.000318	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—CALCA—Paget's disease of bone	4.21e-05	0.000314	CbGpPWpGaD
Nilotinib—LCK—Immune System—INPP5D—Paget's disease of bone	4.2e-05	0.000313	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—VCP—Paget's disease of bone	4.17e-05	0.000311	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—SQSTM1—Paget's disease of bone	3.95e-05	0.000294	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—SQSTM1—Paget's disease of bone	3.91e-05	0.000292	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—CALCA—Paget's disease of bone	3.83e-05	0.000286	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—CALCA—Paget's disease of bone	3.8e-05	0.000283	CbGpPWpGaD
Nilotinib—LCK—Immune System—SQSTM1—Paget's disease of bone	3.77e-05	0.000281	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—INPP5D—Paget's disease of bone	3.71e-05	0.000277	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—NUP205—Paget's disease of bone	3.69e-05	0.000275	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	3.57e-05	0.000266	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—SQSTM1—Paget's disease of bone	3.56e-05	0.000265	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—CALCA—Paget's disease of bone	3.46e-05	0.000258	CbGpPWpGaD
Nilotinib—LCK—Disease—CALCA—Paget's disease of bone	3.38e-05	0.000252	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—SQSTM1—Paget's disease of bone	3.37e-05	0.000251	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—CALCA—Paget's disease of bone	3.27e-05	0.000244	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—INPP5D—Paget's disease of bone	3.15e-05	0.000235	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—SQSTM1—Paget's disease of bone	3.03e-05	0.000226	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—SQSTM1—Paget's disease of bone	2.97e-05	0.000222	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—CALCA—Paget's disease of bone	2.95e-05	0.00022	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—CALCA—Paget's disease of bone	2.88e-05	0.000215	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—SQSTM1—Paget's disease of bone	2.82e-05	0.00021	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—CALCA—Paget's disease of bone	2.73e-05	0.000204	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—NUP205—Paget's disease of bone	2.71e-05	0.000202	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—SQSTM1—Paget's disease of bone	2.43e-05	0.000182	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—CALCA—Paget's disease of bone	2.36e-05	0.000176	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—INPP5D—Paget's disease of bone	2.31e-05	0.000172	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—NUP205—Paget's disease of bone	2.29e-05	0.000171	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—NUP205—Paget's disease of bone	2e-05	0.000149	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—INPP5D—Paget's disease of bone	1.95e-05	0.000146	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—NUP205—Paget's disease of bone	1.88e-05	0.00014	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—NUP205—Paget's disease of bone	1.86e-05	0.000139	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—INPP5D—Paget's disease of bone	1.7e-05	0.000127	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—INPP5D—Paget's disease of bone	1.6e-05	0.00012	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—INPP5D—Paget's disease of bone	1.59e-05	0.000119	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—NUP205—Paget's disease of bone	1.23e-05	9.17e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—INPP5D—Paget's disease of bone	1.05e-05	7.82e-05	CbGpPWpGaD
